Previous close | 139.75 |
Open | 141.37 |
Bid | 142.60 x 1000 |
Ask | 148.25 x 1000 |
Day's range | 139.72 - 143.21 |
52-week range | 71.51 - 143.21 |
Volume | |
Avg. volume | 824,332 |
Market cap | 12.475B |
Beta (5Y monthly) | 1.05 |
PE ratio (TTM) | 19.17 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Comprehensive Analysis of Financial Performance and Market Position
DaVita HealthCare (DVA) delivered earnings and revenue surprises of 21.43% and 2.01%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Improvement in revenue per treatment and cost-saving initiatives are likely to have boosted DaVita's (DVA) top line in the first quarter.